Bill > AB432

This bill addresses menopause-related healthcare provisions across multiple domains. For physicians and surgeons, the bill creates a special continuing medical education (CME) credit incentive where qualifying doctors who complete courses on perimenopause, menopause, and postmenopausal care will receive two hours of credit for each hour of coursework, up to a maximum of eight course hours, from July 1, 2026 to July 1, 2032. A "qualifying physician" is defined as a board-certified specialist in certain fields whose patient population includes at least 25% of adult women under 65. The bill also removes a previous requirement for the Medical Board to consider including menopausal health courses in continuing education. For health insurance and healthcare service plans, starting January 1, 2026, the bill mandates coverage for menopause and perimenopause evaluation and treatment, requiring plans to cover at least one prescription drug in various formulations for hormone therapy, nonhormonal medications, genitourinary syndrome treatments, and osteoporosis prevention. Additionally, insurers and healthcare service plans must annually provide clinical care recommendations for hormone therapy to primary care providers and ensure coverage is provided without discrimination based on gender identity. The bill applies to both health insurance policies and healthcare service plans, with some specific exceptions like Medi-Cal managed care plans.

Budget and Finance, Business and Industry, Health and Social Services

https://leginfo.legislature.ca.gov/faces/billStatusClient.xhtml?bill_id=202520260AB432